GlassScriptPhysician profile
Michelle Guyaux
NPI 1063022580
$1,136.42
in general payments reported to CMS, 2019-2025
13 companies · $501 in 2025
The $501 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $21.57 · 2023: $454 · 2024: $160 · 2025: $501.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,075 · Education: $40.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,074.85 |
| Education | $40.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $268.78 | 2024-2025 | Grafix Pl, Collagenase Santyl |
| Tactile Systems Technology INC | $166.61 | 2025 | Flexitouch Plus, Nimbl |
| Solventum Corporation | $125.19 | 2025 | Activ.A.C. |
| Gilead Sciences, INC. | $125.00 | 2023 | |
| Abbvie INC. | $123.50 | 2023 | |
| Ucb, INC. | $85.72 | 2023 | Fintepla |
| Indivior INC. | $84.06 | 2022-2023 | Sublocade |
| Braeburn INC. | $43.55 | 2023 | Brixadi |
| Urgo Medical North America, LLC | $42.15 | 2025 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap, Drawtex Hydroconductive Wound Dressing With Levafiber 4x4, Urgok2 |
| Biowound Solutions, INC. | $20.86 | 2025 | Bio-Connekt |
| Molnlycke Health Care US, LLC | $19.06 | 2024 | Mextra Superabsorbant, Exufiber, Mepilex Transfer |
| Kerecis Limited | $18.37 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Orexo US, INC. | $13.57 | 2023 | Zubsolv |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michelle Guyaux listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.